Anthropic launches its own drug discovery programs to tackle diseases Big Pharma considers unprofitable

Anthropic is launching an internal drug discovery program focused on developing treatments for diseases that are frequently overlooked by the pharmaceutical industry due to low profitability. By leveraging its large language models to analyze biological data, the company aims to accelerate development timelines and improve the success rates of clinical trials. This effort tests whether generative AI can lower the high capital barriers that typically prevent private firms from pursuing these medical research areas.